Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation. It sells its products through third-party distributors. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.
Frequently asked questions
What sector does BDMD (BDMD) operate in?
BDMD belongs to the Healthcare sector and operates in the Medical Devices industry.
What is BDMD (BDMD) current stock price?
As of the latest data, BDMD stock price is $1.10, with a previous close of $1.13. BDMD lost -$0.03 in the last trading session, representing a -2.74% loss.
What is BDMD (BDMD) current market capitalization?
BDMD market cap is approximately 35.18 million.
What is BDMD (BDMD) Earnings Per Share (EPS)?
The trailing EPS is -$0.97.
What is BDMD (BDMD) EBITDA?
BDMD EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -14.55 million.
Does BDMD (BDMD) pay dividends?
No. BDMD does not pay a dividend.
When is BDMD (BDMD) next earnings report?
BDMD is expected to release its next earnings report on June 30, 2026.
What is BDMD (BDMD) beta (volatility) score?
BDMD has a beta of -1.168, indicating lower volatility than the overall market.
